1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow MASS syndrome: new trials by email Literature Review of MASS syndrome trials Research Report on MASS syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1) · Systemic Vasculitis (1) · Undifferentiated Connective Tissue Diseases (1)
Arthritis (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Rheumatic Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Vascular Diseases (1) · Vasculitis (1)
Paul R Fortin (1)
Canada (1)